Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.055 USD | +0.74% | +4.02% | -30.77% |
Mar. 25 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
Mar. 25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.77% | 386M | |
+30.26% | 699B | |
+25.07% | 571B | |
-4.67% | 364B | |
+18.27% | 326B | |
+2.79% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.56% | 154B |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.
- Needham Adjusts Price Target on Esperion Therapeutics to $9 From $10, Maintains Buy Rating